Skip to Content

Zymaxid Dosage

Generic name: gatifloxacin 5mg in 1mL
Dosage form: ophthalmic solution

Medically reviewed on September 26, 2018.

Day 1: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times.
Day 2 through Day 7: Instill one drop two to four times daily in the affected eye(s) while awake.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Next → Professional

More about Zymaxid (gatifloxacin ophthalmic)

Consumer resources

Other brands: Zymar

Professional resources

Related treatment guides

Antibiotics 101

Drug Status

Rx

Availability Prescription only

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug

Approval History Drug history at FDA

Manufacturer

Allergan plc

Drug Class

Ophthalmic anti-infectives

Related Drugs

Conjunctivitis, Bacterial ciprofloxacin ophthalmic, azithromycin ophthalmic, levofloxacin ophthalmic, erythromycin ophthalmic, gentamicin ophthalmic, bacitracin ophthalmic, tobramycin ophthalmic, moxifloxacin ophthalmic, TobraDex, Vigamox, Maxitrol, More...

Conjunctivitis diclofenac ophthalmic, triamcinolone, dexamethasone ophthalmic, ceftriaxone, Rocephin, Lotemax, cortisone, gatifloxacin ophthalmic, Kenalog-40, Alrex, Maxidex, More...

Zymaxid Rating

No reviews - Add your review

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions and Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Oct 1st, 2018), Cerner Multum™ (updated Oct 2nd, 2018), Wolters Kluwer™ (updated Oct 2nd, 2018) and others. To view content sources and attributions, please refer to our editorial policy.